Shares of San Jose, California-based Altera Corp. (ALTR) declined to $46.97 in the previous session in New York and have risen nearly 6% in pre-market trading Friday, following a NY Post article saying that chip giant Intel (INTC) is close to a $15 billion deal to buy Altera for as much as $54 a share, […]
View the full post at: Pre-Market Buzz: Altera (ALTR), Heron Therapeutics (HRTX), Prima Biomed (PBMD), Transgenomic Inc. (TBIO)